Status:
UNKNOWN
Autologous Bone Marrow Concentration for Rotator Cuff Tear
Lead Sponsor:
Pei-Yuan Lee, MD
Collaborating Sponsors:
Aeon Biotechnology Corporation
Conditions:
Rotator Cuff Tear
Bone Marrow
Eligibility:
All Genders
40-70 years
Brief Summary
This study aims to evaluate the effect of bone marrow concentration on healing of rotator cuff tear by comparing clinical and imaging outcomes between patients receiving arthroscopic repair with intra...
Detailed Description
Rotator cuff tear is a common cause of pain and disability among adults. Most tears are largely caused by the normal wear and tear that goes along with aging. Although nonsurgical treatment relieves p...
Eligibility Criteria
Inclusion
- With diagnosis of rotator cuff tear
- Age between 40 and 70 years
Exclusion
- With prior history of shoulder surgery
- With current or prior history of trauma or infection at shoulder
- With current diagnosis of coagulopathy
- With current or prior history of cancer
- With current or prior history of hematological disease
- Pregnancy
- Patients who will not cooperate with one-year followup
Key Trial Info
Start Date :
May 12 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03792594
Start Date
May 12 2017
End Date
December 1 2020
Last Update
April 14 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Show Chwan Memorial Hospital
Changhua, Changhua, Taiwan, 500